Leap Medical Completes Second Tranche Closing
Montreal, Quebec, Canada. September 29th, 2010 -- Leap Medical Inc., a privately held Medical Device Company, announced today that it has met important milestones in its development plan and has completed the second tranche closing of its seed round. To date, Leap Medical has developed advanced simulations, created sophisticated laboratory phantoms, and successfully demonstrated positive in-vitro testing of its platform technology to non-invasively detect and monitor cerebral bleeds. The second tranche funds will enable it to conduct a first human clinical investigation using its unique technology.
About Leap Medical Inc.
Leap Medical is a Medical Device company dedicated to improving patient outcomes. It is currently focused on developing the first commercial product capable of non-invasively detecting and continuously monitoring brain injuries and infections. Leap Medical’s innovative photonics-based technology is expected to significantly affect the clinical care provided to the millions of patients each year that seek emergency attention for head injuries and severe headaches.
For more information, please contact:
Leap Medical Inc.
Victor Lanzo
President & CEO
514-284-9444, x201
514-284-9184 (fax)